Qwell Pharma Raises $7 Million

Qwell Pharmaceuticals, a Seattle-based drug developer focused on tumors and excess inflammation of skin cells, has raised $7 million in Series A funding, according to Xconomy. Arch Venture Partners and the Wellcome Trust co-led the round. Read more…

Leave a Reply

PE HUB Community

Join the 12519 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget